PMID- 25927497 OWN - NLM STAT- MEDLINE DCOM- 20160119 LR - 20221207 IS - 1478-6362 (Electronic) IS - 1478-6354 (Print) IS - 1478-6354 (Linking) VI - 17 IP - 1 DP - 2015 Apr 18 TI - Anti-citrullinated peptide/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a meta-analysis of genome-wide association study in a Japanese population. PG - 104 LID - 10.1186/s13075-015-0623-4 [doi] LID - 104 AB - INTRODUCTION: Although susceptibility genes for anti-citrullinated peptide/protein antibodies (ACPA)-positive rheumatoid arthritis (RA) have been successfully discovered by genome-wide association studies (GWAS), little is known about the genetic background of ACPA-negative RA. We intended to elucidate genetic background of ACPA-negative RA. METHOD: We performed a meta-analysis of GWAS comprising 670 ACPA-negative RA and 16,891 controls for 1,948,138 markers, followed by a replication study of the top 35 single nucleotide polymorphisms (SNPs) using 916 cases and 3,764 controls. Inverse-variance method was applied to assess overall effects. To assess overlap of susceptibility loci between ACPA-positive and -negative RA, odds ratios (ORs) of the 21 susceptibility markers to RA in Japanese were compared between the two subsets. In addition, SNPs were stratified by the p-values in GWAS meta-analysis for either ACPA-positive RA or ACPA-negative RA to address the question whether weakly-associated genes were also shared. The correlations between ACPA-positive RA and the subpopulations of ACPA-negative RA (rheumatoid factor (RF)-positive and RF-negative subsets) were also addressed. RESULTS: Rs6904716 in LEMD2 of the human leukocyte antigen (HLA) locus showed a borderline association with ACPA-negative RA (overall p = 5.7 x 10(-8)), followed by rs6986423 in CSMD1 (p = 2.4 x 10(-6)) and rs17727339 in FCRL3 (p = 1.4 x 10(-5)). ACPA-negative RA showed significant correlations of ORs with ACPA-positive RA for the 21 susceptibility SNPs and non-HLA SNPs with p-values far from significance. These significant correlations with ACPA-positive RA were true for ACPA-negative RF-positive and ACPA-negative RF-negative RA. On the contrary, positive correlations were not observed between the ACPA-negative two subpopulations. CONCLUSION: Many of the susceptibility loci were shared between ACPA-positive and -negative RA. FAU - Terao, Chikashi AU - Terao C AD - Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. a0001101@kuhp.kyoto-u.ac.jp. FAU - Ohmura, Koichiro AU - Ohmura K AD - Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, 606-8507, Japan. ohmurako@kuhp.kyoto-u.ac.jp. FAU - Kochi, Yuta AU - Kochi Y AD - Laboratory for Autoimmune Diseases, Center for Genomic Medicine, RIKEN, Yokohama, Japan. ykochi@src.riken.jp. FAU - Ikari, Katsunori AU - Ikari K AD - Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan. kikari@mac.com. FAU - Okada, Yukinori AU - Okada Y AD - Department of Human Genetics and Disease Diversity, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. yokada.brc@tmd.ac.jp. FAU - Shimizu, Masakazu AU - Shimizu M AD - Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. shimmy@kuhp.kyoto-u.ac.jp. FAU - Nishina, Naoshi AU - Nishina N AD - Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. nnnmd11@hotmail.com. FAU - Suzuki, Akari AU - Suzuki A AD - Laboratory for Autoimmune Diseases, Center for Genomic Medicine, RIKEN, Yokohama, Japan. akaris@src.riken.jp. FAU - Myouzen, Keiko AU - Myouzen K AD - Laboratory for Autoimmune Diseases, Center for Genomic Medicine, RIKEN, Yokohama, Japan. keimyouzen@src.riken.jp. FAU - Kawaguchi, Takahisa AU - Kawaguchi T AD - Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. tkawa@genome.med.kyoto-u.ac.jp. FAU - Takahashi, Meiko AU - Takahashi M AD - Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. meiko@genome.med.kyoto-u.ac.jp. FAU - Takasugi, Kiyoshi AU - Takasugi K AD - Dohgo Spa Hospital, Matsuyama, Japan. keetakas@ehime.med.or.jp. FAU - Murasawa, Akira AU - Murasawa A AD - Department of Rheumatology, Niigata Rheumatic Center, Niigata, Japan. med@ra-center.com. FAU - Mizuki, Shinichi AU - Mizuki S AD - The Centre for Rheumatic Diseases, Matsuyama Red Cross Hospital, Matsuyama, Japan. smizuki@matsuyama.jrc.or.jp. FAU - Iwahashi, Mitsuhiro AU - Iwahashi M AD - Higashihiroshima Memorial Hospital, Hiroshima, Japan. ajisu@hotmail.com. FAU - Funahashi, Keiko AU - Funahashi K AD - Pharm C, Matsubara Mayflower Hospital, 944-25 Fujita, Kato City, Hyogo, Japan. kansetsusaisei123@cup.ocn.ne.jp. FAU - Natsumeda, Masamitsu AU - Natsumeda M AD - Kurashiki Sweet Hospital, Kurashiki, Japan. zaraspook3hook@yahoo.co.jp. FAU - Furu, Moritoshi AU - Furu M AD - Department of the Control for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan. morifuru@kuhp.kyoto-u.ac.jp. FAU - Hashimoto, Motomu AU - Hashimoto M AD - Department of the Control for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan. mohashim@kuhp.kyoto-u.ac.jp. FAU - Ito, Hiromu AU - Ito H AD - Department of the Control for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan. hiromu@kuhp.kyoto-u.ac.jp. FAU - Fujii, Takao AU - Fujii T AD - Department of the Control for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan. takfujii@kuhp.kyoto-u.ac.jp. FAU - Ezawa, Kazuhiko AU - Ezawa K AD - Kurashiki Sweet Hospital, Kurashiki, Japan. ky-6182@rice.ocn.ne.jp. FAU - Matsubara, Tsukasa AU - Matsubara T AD - Matsubara Mayflower Hospital, 944-25 Fujita, Kato City, Hyogo, Japan. mats@mayflower-hp.jp. FAU - Takeuchi, Tsutomu AU - Takeuchi T AD - Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. tsutake@z5.keio.jp. FAU - Kubo, Michiaki AU - Kubo M AD - Laboratory for Autoimmune Diseases, Center for Genomic Medicine, RIKEN, Yokohama, Japan. mkubo@src.riken.jp. FAU - Yamada, Ryo AU - Yamada R AD - Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. ryamada@genome.med.kyoto-u.ac.jp. FAU - Taniguchi, Atsuo AU - Taniguchi A AD - Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan. amtanigu@ior.twmu.ac.jp. FAU - Yamanaka, Hisashi AU - Yamanaka H AD - Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan. yamanaka@ior.twmu.ac.jp. FAU - Momohara, Shigeki AU - Momohara S AD - Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan. smomohara@ior.twmu.ac.jp. FAU - Yamamoto, Kazuhiko AU - Yamamoto K AD - Laboratory for Autoimmune Diseases, Center for Genomic Medicine, RIKEN, Yokohama, Japan. yamamoto-tky@umin.ac.jp. FAU - Mimori, Tsuneyo AU - Mimori T AD - Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, 606-8507, Japan. mimorit@kuhp.kyoto-u.ac.jp. FAU - Matsuda, Fumihiko AU - Matsuda F AD - Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. fumi@genome.med.kyoto-u.ac.jp. AD - Institut National de la Sante et de la Recherche Medicale (INSERM) Unite U852, Kyoto University Graduate School of Medicine, Kyoto, Japan. fumi@genome.med.kyoto-u.ac.jp. LA - eng PT - Comparative Study PT - Journal Article PT - Meta-Analysis PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20150418 PL - England TA - Arthritis Res Ther JT - Arthritis research & therapy JID - 101154438 RN - 0 (Peptides, Cyclic) RN - 0 (cyclic citrullinated peptide) SB - IM MH - Arthritis, Rheumatoid/ethnology/*genetics/immunology MH - Asian People/*genetics MH - Female MH - Genetic Loci MH - Genetic Predisposition to Disease/*epidemiology MH - *Genome-Wide Association Study MH - Genotype MH - Humans MH - Japan MH - Male MH - Peptides, Cyclic/*genetics/immunology MH - Polymorphism, Single Nucleotide MH - Reference Values PMC - PMC4431175 EDAT- 2015/05/01 06:00 MHDA- 2016/01/20 06:00 PMCR- 2015/04/18 CRDT- 2015/05/01 06:00 PHST- 2014/07/28 00:00 [received] PHST- 2015/04/08 00:00 [accepted] PHST- 2015/05/01 06:00 [entrez] PHST- 2015/05/01 06:00 [pubmed] PHST- 2016/01/20 06:00 [medline] PHST- 2015/04/18 00:00 [pmc-release] AID - 10.1186/s13075-015-0623-4 [pii] AID - 623 [pii] AID - 10.1186/s13075-015-0623-4 [doi] PST - epublish SO - Arthritis Res Ther. 2015 Apr 18;17(1):104. doi: 10.1186/s13075-015-0623-4.